Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Urinary sodium in the evaluation of hyperchloremic metabolic acidosis.
Batlle DC, von Riotte A, Schlueter W. Batlle DC, et al. Among authors: schlueter w. N Engl J Med. 1987 Jan 15;316(3):140-4. doi: 10.1056/NEJM198701153160305. N Engl J Med. 1987. PMID: 3796685 No abstract available.
On the mechanism of impaired distal acidification in hyperkalemic renal tubular acidosis: evaluation with amiloride and bumetanide.
Schlueter W, Keilani T, Hizon M, Kaplan B, Batlle DC. Schlueter W, et al. J Am Soc Nephrol. 1992 Oct;3(4):953-64. J Am Soc Nephrol. 1992. PMID: 1450372
Distal renal tubular acidosis and the potassium enigma.
Batlle D, Moorthi KM, Schlueter W, Kurtzman N. Batlle D, et al. Among authors: schlueter w. Semin Nephrol. 2006 Nov;26(6):471-8. doi: 10.1016/j.semnephrol.2006.12.001. Semin Nephrol. 2006. PMID: 17275585 Review.
Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium.
Keilani T, Schlueter W, Batlle D. Keilani T, et al. Among authors: schlueter w. J Clin Pharmacol. 1995 Jan;35(1):87-97. doi: 10.1002/j.1552-4604.1995.tb04750.x. J Clin Pharmacol. 1995. PMID: 7751417 Review.
Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
Schlueter W, Keilani T, Batlle DC. Schlueter W, et al. Am J Med Sci. 1994 Feb;307 Suppl 1:S81-6. Am J Med Sci. 1994. PMID: 8141171 Review.
Chronic obstructive nephropathy.
Schlueter W, Batlle DC. Schlueter W, et al. Semin Nephrol. 1988 Mar;8(1):17-28. Semin Nephrol. 1988. PMID: 3283892 Review. No abstract available.
Assessment of collecting tubule hydrogen ion secretion in acute respiratory alkalosis using the urinary pCO2.
Batlle DC, Schlueter W, Gutterman C, Kurtzman NA. Batlle DC, et al. Among authors: schlueter w. Pflugers Arch. 1988 Jun;411(6):692-4. doi: 10.1007/BF00580868. Pflugers Arch. 1988. PMID: 3137524
Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
Keilani T, Schlueter WA, Levin ML, Batlle DC. Keilani T, et al. Among authors: schlueter wa. Ann Intern Med. 1993 Feb 15;118(4):246-54. doi: 10.7326/0003-4819-118-4-199302150-00002. Ann Intern Med. 1993. PMID: 8420442 Clinical Trial.
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
Schlueter W, Keilani T, Batlle DC. Schlueter W, et al. Am J Cardiol. 1993 Dec 30;72(20):37H-44H. doi: 10.1016/0002-9149(93)91053-k. Am J Cardiol. 1993. PMID: 8285181 Review.
Renal effects of antihypertensive drugs.
Schlueter WA, Batlle DC. Schlueter WA, et al. Drugs. 1989 Jun;37(6):900-25. doi: 10.2165/00003495-198937060-00005. Drugs. 1989. PMID: 2667938 Review.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback